5-[2-(pyrrolidin-1-yl)ethoxy]-p-cymene derivatives, the process

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548575, A61K 3140, C07D29508

Patent

active

047957581

ABSTRACT:
The present invention relates to novel products of the formula: ##STR1## in which R is selected from the group comprising H, OH, --O--COCH.sub.3 and --O--CO--(CH.sub.2).sub.n --CH.sub.3, in which n is between 1 and 8, and the salts of the products of the formula (I) with pharmaceutically acceptable acids.

REFERENCES:
patent: 2914552 (1959-11-01), Hiltmann et al.
patent: 3205136 (1965-09-01), Tedeschi
patent: 3740397 (1973-06-01), Lafon
patent: 3767819 (1973-10-01), Leeming et al.
patent: 3793366 (1974-02-01), Krapcho
Wheatley, et al., J. Org. Chem., 23, 568-571.
Goodman et al., "The Pharmacological Basis of Therapeutics", pp. 549-565, Chapter 26 (1970), 4th Ed., The Macmillan Co., London.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5-[2-(pyrrolidin-1-yl)ethoxy]-p-cymene derivatives, the process does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-[2-(pyrrolidin-1-yl)ethoxy]-p-cymene derivatives, the process , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-[2-(pyrrolidin-1-yl)ethoxy]-p-cymene derivatives, the process will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2168689

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.